Study Examines Effects of Cranberries on Women’s UTI
The 90-day, randomized, double-blind, controlled study administered a daily dose of 500 mg of PACran.
Decas Botanical Synergies (Carver, MA) announced the publication of a study in Current Bioactive Compounds examining the effects of the company’s PACran cranberry supplement on women with recurring urinary tract infections (UTIs) and a confirmed presence of E. coli in the culture of urine samples.
The 90-day, randomized, double-blind, controlled study administered a daily dose of 500 mg of PACran. The company says that at the end of the treatment period, results showed a significant reduction in the presence of E. coli and support for urinary tract health.
WIN to host networking event and partner on education session at SupplySide East 2024
April 2nd 2024At this year’s SupplySide East, taking place on April 16 and 17 in Secaucus, NJ, Women in Nutraceuticals (WIN) will be hosting a networking event and partnering on an education session titled “Substantiating Products for Women – Building Trust Through Science.”
